Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells

Jitender Monga(Henry Ford Health System), J. J. Ghosh(Henry Ford Health System)
Molecular Cancer Therapeutics
January 11, 2023
Cited by 6


Related Papers